PGLYRP1 and Immunodeficiency: The immune deficiency (IMD) pathway is activated upon stimulation of PGRPs by the Gram-negative diaminopimelic acid (DAP)-type peptidoglycan, which stimulates both soluble and transmembrane PGRPs.